1. Home
  2. VTAK vs XXII Comparison

VTAK vs XXII Comparison

Compare VTAK & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Catheter Precision Inc.

VTAK

Catheter Precision Inc.

HOLD

Current Price

$0.95

Market Cap

3.0M

Sector

Health Care

ML Signal

HOLD

Logo 22nd Century Group Inc.

XXII

22nd Century Group Inc.

HOLD

Current Price

$0.85

Market Cap

3.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTAK
XXII
Founded
2002
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0M
3.3M
IPO Year
2018
2011

Fundamental Metrics

Financial Performance
Metric
VTAK
XXII
Price
$0.95
$0.85
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
163.3K
850.8K
Earning Date
08-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
89.53
69.96
EPS
N/A
N/A
Revenue
$442,000.00
$25,832,530.00
Revenue This Year
$1,170.33
$370.28
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3057.14
N/A
52 Week Low
$0.15
$0.67
52 Week High
$4.31
$11.37

Technical Indicators

Market Signals
Indicator
VTAK
XXII
Relative Strength Index (RSI) 40.76 19.51
Support Level $0.88 $0.71
Resistance Level $1.28 $1.10
Average True Range (ATR) 0.08 0.26
MACD 0.02 -0.03
Stochastic Oscillator 53.76 3.36

Price Performance

Historical Comparison
VTAK
XXII

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.

About XXII 22nd Century Group Inc.

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.

Share on Social Networks: